Selective susceptibility of transformed T lymphocytes to induction of apoptosis by PSC 833, an inhibitor of P-glycoprotein

Oncology Research

Volumn 12, Issue 8, 2000, Pages 315-323

  Azare, Janeen ^a   Pankova Kholmyansky, Irene ^b   Salnikow, Konstantin ^a   Cohen, Dalia ^c   Flescher, Eliezer ^b  

^a NEW YORK UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b TEL AVIV UNIVERSITY   (Israel)

^c NOVARTIS INSTITUTES FOR BIOMEDICAL RESEARCH   (United States)

Author keywords

Apoptosis; Ceramide; Lymphoma; P glycoprotein; PSC 833; T lymphocytes

Indexed keywords

ANTINEOPLASTIC AGENT; CERAMIDE; CYCLOSERINE; CYCLOSPORIN DERIVATIVE; DIACYLGLYCEROL KINASE; DNA; DNA FRAGMENT; GLYCOPROTEIN P; VALSPODAR;

APOPTOSIS; ARTICLE; BIOSYNTHESIS; CELL CULTURE; CELL LINE; COMPARATIVE STUDY; DRUG ANTAGONISM; DRUG EFFECT; DRUG RESISTANCE; DRUG SCREENING; FLOW CYTOMETRY; HUMAN; LEUKEMIA CELL LINE; METABOLISM; MULTIDRUG RESISTANCE; PATHOLOGY; T CELL LEUKEMIA; T LYMPHOCYTE;

ANTINEOPLASTIC AGENTS; APOPTOSIS; CELL LINE, TRANSFORMED; CERAMIDES; CYCLOSERINE; CYCLOSPORINS; DIACYLGLYCEROL KINASE; DNA FRAGMENTATION; DNA, NEOPLASM; DRUG RESISTANCE, MULTIPLE; DRUG RESISTANCE, NEOPLASM; DRUG SCREENING ASSAYS, ANTITUMOR; FLOW CYTOMETRY; HUMANS; JURKAT CELLS; LEUKEMIA, T-CELL; P-GLYCOPROTEIN; T-LYMPHOCYTES; TUMOR CELLS, CULTURED;

EID: 0034574938     PISSN: 09650407     EISSN: None     Source Type: Journal    
DOI: 10.3727/096504001108747765     Document Type: Article

References (40)

1. Fisher, G. A.; Sikic, B. I. Clinical studies with modulators of multidrug resistance. Hematol. Oncol. Clin. North Am. 9:363-382; 1995.
2. Sonneveld, P.; Lokhorst, H. M.; Vossebeld, P. Drug resistance in multiple myeloma. Semin. Hematol. 34:34-39; 1997.
3. Hickman, J. A. Apoptosis induced by anticancer drugs. Cancer Metastasis Rev. 11:121-139; 1992.
4. Frankfurt, O. S.; Seckinger, D.; Sugarbaker, E. V. Apoptosis and growth inhibition in sensitive and resistant leukemic cells treated with anticancer drugs. Int. J. Oncol. 4:481-489; 1994.
5. Meyn, R. E.; Stephens, L. C.; Hunter, N. R.; Milas, L. Apoptosis in murine tumors treated with chemotherapy agents. Anticancer Drugs 6:443-450; 1995.
6. Stewart, B. W. Mechanisms of apoptosis: Integration of genetic, biochemical, and cellular indicators. J. Natl. Cancer Inst. 86: 1286-1296; 1994.
7. Robertson, J. D.; Orrenius, S.; Zhivotovsky, B. Review: Nuclear events in apoptosis. J. Struct. Biol. 129:346-358; 2000.
8. Archinal-Mattheis, A.; Rzepka, R. W.; Watanabe, T.; Kokubu, N.; Itoh, Y.; Combates, N. J.; Bair, K. W.; Cohen, D. Analysis of the interactions of SDZ PSC 833 ([3′-keto Bmt1-Val2]-cyclosporine), a multidrug resistance modulator, with P-glycoprotein. Oncol. Res. 7:603-610; 1995.
9. Boesch, D.; Muller, K.; Pourtier-Manzanedo, A.; Loor, F. Restoration of daunomycin retention in multidrug-resistant P388 cells by submicromolar concentrations of SDZ PSC 833, a nonimmunosuppressive cyclosporin derivative. Exp. Cell Res. 196:26-32; 1991.
10. Jiang, X.-R.; Kelsey, S. M.; Wu, Y.-L.; Newland, A. C. Circumvention of P-glycoprotein-mediated drug resistance in human leukemic cells by non-immunosuppressive cyclosporin D analogue, SDZ PSC 833. Br. J. Haematol. 90:375-383; 1995.
11. Grey, M.; Borg, A. G.; Wood, P.; Burgess, R.; Fisher, A.; Yin, J. A. Effect on cell kill of addition of multidrug resistance modifiers cyclosporin A and PSC 833 to cytotoxic agents in acute myeloid leukemia. Leuk. Res. 21:867-874; 1997.
12. Lehne, G.; Rugstad, H. E. Cytotoxic effect of the cyclosporin PSC 833 in multidrug-resistant leukaemia cells with increased expression of P-glycoprotein. Br. J. Cancer 78:593-600; 1998.
13. Lehne, G.; De Angelis, P.; den Boer, M.; Rugstad, H. E. Growth inhibition, cytokinesis failure and apoptosis of multidrug-resistant leukemia cells after treatment with P-glycoprotein inhibitory agents. Leukemia 13:768-778; 1999.
14. Cabot, M. C.; Han, T.-Y.; Giuliano, A. E. The multidrug resistance modulator SDZ PSC 833 is a potent activator of cellular ceramide formation. FEBS Lett. 431:185-188; 1998.
15. Cabot, M. C.; Giuliano, A. E.; Han, T.-Y.; Liu, Y.-Y. SDZ PSC 833, the cyclosporine A analogue and multidrug resistance modulator, activates ceramide synthesis and increases vinblastine sensitivity in drug-sensitive and drug-resistant cancer cells. Cancer Res. 59:880-885; 1999.
16. Chaudhary, P. M.; Mechetner, E. B.; Roninson, I. B. Expression and activity of the multidrug resistance P-glycoprotein in human peripheral blood lymphocytes. Blood 80:2735-2739; 1992.
17. Damiani, D.; Michieli, M.; Michelutti, A.; Geromin, A.; Raspadori, D.; Fanin, R.; Savignano, C.; Giacca, M.; Pileri, S.; Malolardi, F.; Baccarani, M. Expression of multidrug resistance gene (MDR-1) in human normal leukocytes. Haematologica 78:12-17; 1993.
18. Gupta, S.; Aggarwal, S. P-glycoprotein in cells of the human immune system. Immunologist 4:86-90; 1996.
19. Aggarwal, S.; Tsuruo, T.; Gupta, S. Altered expression and function of P-glycoprotein (170 kDa), encoded by the MDR 1 gene, in T cell subsets from aging humans. J. Clin. Immunol. 17:448-454; 1997.
20. Mu, X. Y.; Gosland, M. P.; Bartik, M. M.; Schimmelpfennig, J.; Kay, N. E. Activation of human peripheral blood T cells does not lead to increased P-glycoprotein expression. J. Clin. Immunol.. 19:239-246; 1999.
21. Drach, J.; Gsur, A.; Hamilton, G.; Zhao, S.; Angerler, J.; Fiegl, M.; Zojer, N.; Raderer, M.; Haberl, I.; Andreeff, M.; Huber, H. Involvement of P-glycoprotein in the transmembrane transport of interleukin-2 (IL-2), IL-4, and interferon-gamma in normal human T lymphocytes. Blood 88:1747-1754; 1996.
22. Flescher, E.; Fossum, D.; Gray, P. J.; Fernandes, G.; Harper, M. J. K.; Talal, N. Aspirin-like drugs prime human T cells. Modulation of intracellular calcium concentrations. J. Immunol. 146: 2553-2559; 1991.
23. Flescher, E.; Ledbetter, J. A.; Ogawa, N.; Vela-Roch, N.; Fossum, D.; Dang, H.; Talal, N. Induction of transcription factors in human T lymphocytes by aspirin-like drugs. Cell. Immunol. 160:232-239; 1995.
24. Basnakian, A. G.; James, S. J. A rapid and sensitive assay for the detection of DNA fragmentation during early phases of apoptosis. Nucleic Acids Res. 22:2714-2715; 1994.
25. Nicoletti, I.; Migliorati, G.; Pagliacci, M.C.; Grignani, F.; Riccardi, C. A. Rapid and simple method measuring thymocyte apoptosis by propidium iodide staining and flow cytometry. J. Immunol. Methods 139:271-279; 1991.
26. Dressler, K. A.; Kolesnick, R. N. Ceramide 1-phosphate, a novel phospholipid in human leukemia (HL-60) cells. J. Biol. Chem. 265:14917-14921; 1990.
27. Rotem, R.; Tzivony, Y.; Flescher, E. Contrasting effects of aspirin on prostate cancer cells: Suppression of proliferation and induction of drug resistance. Prostate 42:172-180; 2000.
28. Klimecki, W. T.; Taylor, C. W.; Dalton, W. S. Inhibition of cell-mediated cytolysis and P-glycoprotein function in natural killer cells by verapamil isomers and cyclosporine A analogs. J. Clin. Immunol. 15:152-158; 1995.
29. Gonzalez, O.; Colombo, T.; De Fusco, M.; Imperatori, L.; Zucchetti, M.; D'Incalci, M. Changes in doxorubicin distribution and toxicity in mice pretreated with the cyclosporin analogue SDZ PSC 833. Cancer Chemother. Pharmacol. 36:335-340; 1995.
30. Mansat-De Mas, V.; Bezombes, C.; Quillet-Mary, A.; Bettaieb, A.; De Thonel D'orgeix, A.; Laurent, G.; Jaffrezou, J.-P. Implication of radical oxygen species in ceramide generation, c-Jun N-terminal kinase activation and apoptosis induced by daunorubicin. Mol. Pharmacol. 56:867-874; 1999.
31. Gupta, S.; Kim, C. H.; Tsuruo, T.; Gollapudi, S. Preferential expression and activity of multidrug resistance gene 1 product (P-glycoprotein), a functionally active efflux pump, in human CD8+ T cells: A role in cytotoxic effector function. J. Clin. Immunol. 12:451-458; 1992.
32. Coon, J. S.; Wang, Y.; Bines, S. D.; Markham, P. N.; Chong, A. S. F.; Gebel, H. M. Multidrug resistance activity in human lymphocytes. Hum. Immunol. 32:134-140; 1991.
33. Wesselborg, S.; Janssen, O.; Kabelitz, D. Induction of activation-driven death (apoptosis) in activated but not resting peripheral blood T cells. J. Immunol. 50:4338-4345; 1993.
34. Spinedi, A.; Di Bartolomeo, S.; Di Sano, F.; Rodolfo, C.; Ambrosino, A.; Piacentini, M. Ceramide accumulation precedes caspase-dependent apoptosis in CHP-100 neuroepithelioma cells exposed to the protein phosphatase inhibitor okadaic acid. Cell Death Differ. 6:618-623; 1999.
35. Delpy, E.; Hatem, S. N.; Andrieu, N.; de Vaumas, C.; Henaff, M.; Rucker-Martin, C.; Jaffrezou, J.-P.; Laurent, G.; Levade, T.; Mercadier, J.-J. Doxorubicin induces slow ceramide accumulation and late apoptosis in cultured adult rat ventricular myocytes. Cardiovas. Res. 43:398-407; 1999.
36. Kreis, W.; Budman, D. R.; Calabro, A. Unique synergism or antagonism of combinations of chemotherapeutic and hormonal agents in human prostate cancer cell lines. Br. J. Urol. 79:196-202; 1997.
37. Earnshaw, W. C. Apoptosis: Lessons from in vitro systems. Trends Cell Biol. 5:217-220; 1995.
38. Flescher, E.; Rotem, R.; Kwon, P.; Azare, J.; Jaspers, I.; Cohen, D. Aspirin enhances multidrug resistance gene 1 expression in human Molt-4 T lymphoma cells. Anticancer Res. 20:4441-4444; 2000.
39. Martel, J.; Payet, M. D.; Dupuis, G. The MDR1 (P-glycoprotein) and MRP (P-190) transporters do not play a major role in the intrinsic multiple drug resistance of Jurkat T lymphocytes. Leuk. Res. 21:1077-1086; 1997.
40. De Maria, R.; Boirivant, M.; Cifone, M. G.; Roncaioli, P.; Hahne, M.; Tschopp, J.; Pallone, F.; Santoni, A.; Testi, R. Functional expression of Fas and Fas ligand on human gut lamina Propria T lymphocytes. J. Clin. Invest. 97:316-322; 1996.